Synthesis and antitumor activity of natural compound aloe emodin derivatives. 2015

Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
World Class Institute (WCI), Incurable Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, 363-883, Korea; Department of Chemistry, Govt.S K S J T Institute, Bangalore, Karnataka, 560001, India.

In this study, we have synthesized novel water soluble derivatives of natural compound aloe emodin 4(a-j) by coupling with various amino acid esters and substituted aromatic amines, in an attempt to improve the anticancer activity and to explore the structure-activity relationships. The structures of the compounds were determined by (1) H NMR and mass spectroscopy. Cell growth inhibition assays revealed that the aloe emodin derivatives 4d, 4f, and 4i effectively decreased the growth of HepG2 (human liver cancer cells) and NCI-H460 (human lung cancer cells) and some of the derivatives exhibited comparable antitumor activity against HeLa (Human epithelial carcinoma cells) and PC3 (prostate cancer cells) cell lines compared to that of the parent aloe emodin at low micromolar concentrations.

UI MeSH Term Description Entries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000880 Anthraquinones Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups. Anthracenedione,Anthracenediones,Anthranoid,Anthraquinone,Anthraquinone Compound,Anthraquinone Derivative,Dianthraquinones,Dianthrones,Anthranoids,Anthraquinone Compounds,Anthraquinone Derivatives,Compound, Anthraquinone,Derivative, Anthraquinone
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
October 2012, European journal of medicinal chemistry,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
September 2021, International journal of cancer,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
September 2022, Molecules (Basel, Switzerland),
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
February 2012, Natural product communications,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
March 2013, Bioorganic & medicinal chemistry,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
February 2021, Chemical biology & drug design,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
March 2014, European journal of medicinal chemistry,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
September 2010, Molecules (Basel, Switzerland),
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
May 2021, RSC medicinal chemistry,
Naraganahalli R Thimmegowda, and Chanmi Park, and Bettaswamigowda Shwetha, and Krisada Sakchaisri, and Kangdong Liu, and Joonsung Hwang, and Sangku Lee, and Sook J Jeong, and Nak K Soung, and Jae H Jang, and In-Ja Ryoo, and Jong S Ahn, and Raymond L Erikson, and Bo Y Kim
August 2010, Life sciences,
Copied contents to your clipboard!